 Since the establishment of NICE in 1999 there has been a move to more robust processes, but such decisions always generate controversy.These lists are now decided by clinical commissioning groups in England, but rules differ in Wales, Scotland and Northern Ireland.Restrictions on one kind of treatment for a condition may lead to patients getting different, and possibly more expensive treatment.